| [1] |
Cheng LX, Cao Y, Liu SH, et al. Unveiling the research advances of sepsis: pathogenesis, precise intervention and clinical perspective[J]. Int J Surg, 2025, 111(9): 6260-89. doi:10.1097/js9.0000000000002668
|
| [2] |
Qiu N, Xu XM, He YY. LncRNA TUG1 alleviates sepsis-induced acute lung injury by targeting miR-34b-5p/GAB1[J]. BMC Pulm Med, 2020, 20(1): 49. doi:10.1186/s12890-020-1084-3
|
| [3] |
Qiao XY, Yin JH, Zheng ZH, et al. Endothelial cell dynamics in sepsis-induced acute lung injury and acute respiratory distress syndrome: pathogenesis and therapeutic implications[J]. Cell Commun Signal, 2024, 22(1): 241. doi:10.1186/s12964-024-01620-y
|
| [4] |
Gao M, Yu TY, Liu D, et al. Sepsis plasma-derived exosomal miR-1-3p induces endothelial cell dysfunction by targeting SERP1[J]. Clin Sci, 2021, 135(2): 347-65. doi:10.1042/cs20200573
|
| [5] |
Birukova AA, Tian XY, Cokic I, et al. Endothelial barrier disruption and recovery is controlled by substrate stiffness[J]. Microvasc Res, 2013, 87: 50-7. doi:10.1016/j.mvr.2012.12.006
|
| [6] |
Rotoli BM, Barilli A, Visigalli R, et al. Endothelial cell activation by SARS-CoV-2 spike S1 protein: a crosstalk between endothelium and innate immune cells[J]. Biomedicines, 2021, 9(9): 1220. doi:10.3390/biomedicines9091220
|
| [7] |
Lee W, Choi HJ, Sim H, et al. Barrier protective functions of hederacolchiside-E against HMGB1-mediated septic responses[J]. Pharmacol Res, 2021, 163: 105318. doi:10.1016/j.phrs.2020.105318
|
| [8] |
Devireddy LR, Gazin C, Zhu XC, et al. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake[J]. Cell, 2005, 123(7): 1293-305. doi:10.1016/j.cell.2005.10.027
|
| [9] |
Sun SC. The non-canonical NF‑κB pathway in immunity and inflammation[J]. Nat Rev Immunol, 2017, 17(9): 545-58. doi:10.1038/nri.2017.52
|
| [10] |
Lawrence T. The nuclear factor NF-kappaB pathway in inflammation[J]. Cold Spring Harb Perspect Biol, 2009, 1(6): a001651. doi:10.1101/cshperspect.a001651
|
| [11] |
Luo MH, Meng JY, Yan JH, et al. Role of the nucleotide-binding domain-like receptor protein 3 inflammasome in the endothelial dysfunction of early sepsis[J]. Inflammation, 2020, 43(4): 1561-71. doi:10.1007/s10753-020-01232-x
|
| [12] |
Grimsley-Myers CM, Isaacson RH, Cadwell CM, et al. VE-cadherin endocytosis controls vascular integrity and patterning during development[J]. J Cell Biol, 2020, 219(5): e201909081. doi:10.1083/jcb.201909081
|
| [13] |
王奕人, 于梦洁, 杜若丽, 等. LCN2基因敲除可能通过抑制TLR4/NF-κB信号通路改善脓毒症小鼠肺损伤和铁死亡[J/OL]. 生理学报, 2025. doi: 10.13294/j.aps.2025.0070
|
| [14] |
Barkat MQ, Li Q, Manzoor M, et al. Sepsis-induced ALI/ARDS beyond supportive care: molecular mechanisms and cutting-edge therapies[J]. Int Immunopharmacol, 2025, 166: 115495. doi:10.1016/j.intimp.2025.115495
|
| [15] |
Su YC, Lucas R, Fulton DJR, et al. Mechanisms of pulmonary endothelial barrier dysfunction in acute lung injury and acute respiratory distress syndrome[J]. Chin Med J Pulm Crit Care Med, 2024, 2(2): 80-7. doi:10.1016/j.pccm.2024.04.002
|
| [16] |
Vassiliou AG, Kotanidou A, Dimopoulou I, et al. Endothelial damage in acute respiratory distress syndrome[J]. Int J Mol Sci, 2020, 21(22): 8793. doi:10.3390/ijms21228793
|
| [17] |
Tang F, Zhao XL, Xu LY, et al. Endothelial dysfunction: Pathophysiology and therapeutic targets for sepsis-induced multiple organ dysfunction syndrome[J]. Biomed Pharmacother, 2024, 178: 117180. doi:10.1016/j.biopha.2024.117180
|
| [18] |
Watanabe E, Akamatsu T, Ohmori M, et al. Recombinant thrombomodulin attenuates hyper-inflammation and glycocalyx damage in a murine model of Streptococcus pneumoniae-induced sepsis[J]. Cytokine, 2022, 149: 155723. doi:10.1016/j.cyto.2021.155723
|
| [19] |
Ahn H, Lee G, Kim J, et al. NLRP3 triggers attenuate lipocalin-2 expression independent with inflammasome activation[J]. Cells, 2021, 10(7): 1660. doi:10.3390/cells10071660
|
| [20] |
Guo H, Jin DZ, Chen XL. Lipocalin 2 is a regulator of macrophage polarization and NF‑κB/STAT3 pathway activation[J]. Mol Endocrinol, 2014, 28(10): 1616-28. doi:10.1210/me.2014-1092
|
| [21] |
Su XJ, Zhou PP, Qi YX. Down-regulation of LCN2 attenuates retinal vascular dysfunction and caspase-1-mediated pyroptosis in diabetes mellitus[J]. Ann Transl Med, 2022, 10(12): 695. doi:10.21037/atm-22-2655
|
| [22] |
Singh V, Kaur R, Kumari P, et al. ICAM-1 and VCAM-1: Gatekeepers in various inflammatory and cardiovascular disorders[J]. Clin Chim Acta, 2023, 548: 117487. doi:10.1016/j.cca.2023.117487
|
| [23] |
He JW, Duan ML, Zhuang HZ. ICAM1 and VCAM1 are associated with outcome in patients with sepsis: a systematic review and meta-analysis[J]. Heliyon, 2024, 10(21): e40003. doi:10.1016/j.heliyon.2024.e40003
|
| [24] |
Flemming S, Burkard N, Renschler M, et al. Soluble VE-cadherin is involved in endothelial barrier breakdown in systemic inflammation and sepsis[J]. Cardiovasc Res, 2015, 107(1): 32-44. doi:10.1093/cvr/cvv144
|
| [25] |
Shadab M, Slavin SA, Mahamed Z, et al. Spleen Tyrosine Kinase phosphorylates VE-cadherin to cause endothelial barrier disruption in acute lung injury[J]. J Biol Chem, 2023, 299(12): 105408. doi:10.1016/j.jbc.2023.105408
|
| [26] |
Wang LN, Cao YP, Gorshkov B, et al. Ablation of endothelial Pfkfb3 protects mice from acute lung injury in LPS-induced endotoxemia[J]. Pharmacol Res, 2019, 146: 104292. doi:10.1016/j.phrs.2019.104292
|
| [27] |
Minami T, Aird WC. Endothelial cell gene regulation[J]. Trends Cardiovasc Med, 2005, 15(5): 174-84. doi:10.1016/j.tcm.2005.06.002
|
| [28] |
Cai JN, Wang YL, Sheng XD, et al. Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB to alleviate LPS-induced ALI[J]. J Ethnopharmacol, 2022, 298: 115661. doi:10.1016/j.jep.2022.115661
|
| [29] |
Zhao HK, Wu L, Yan GF, et al. Inflammation and tumor progression: signaling pathways and targeted intervention[J]. Signal Transduct Target Ther, 2021, 6(1): 263. doi:10.1038/s41392-021-00658-5
|